EarlySight is a Swiss startup company focused on reducing vision-loss by enabling earlier detection and better monitoring of eye degenerative diseases.
The company was founded in March 2019 as a spinoff of the Swiss Federal Institute of Technology in Lausanne (EPFL). It uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.
The eye imaging device in development observes the cells affected at early-stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma, or diabetic retinopathy, with the expected goal to enable earlier diagnoses and more efficient treatments.
The company was founded in March 2019 as a spinoff of the Swiss Federal Institute of Technology in Lausanne (EPFL). It uses a novel approach to provide a single cell level imaging of the back of the eye, called the retina.
The eye imaging device in development observes the cells affected at early-stage of the most prevalent retinal diseases such as age-related macular degeneration, glaucoma, or diabetic retinopathy, with the expected goal to enable earlier diagnoses and more efficient treatments.
Informations clés
- Technique médicale
- Avenue de Sécheron 15, 1202 Genève
- EarlySight SA
De nouveaux emplois directement dans votre mailbox?
Il n'y a actuellement aucune offre d'emploi. Suivez cette entreprise et nous vous informerons dès que de nouveaux emplois seront disponibles.
Pas encore d'avis
Aidez les autres en partageant votre expérience avec cette entreprise en tant qu'employé ou candidat.